KBC Group’s Keros Therapeutics KROS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q1
Sell
-1,622
Closed -$26K 1887
2024
Q4
$26K Buy
1,622
+359
+28% +$5.76K ﹤0.01% 1828
2024
Q3
$73K Buy
1,263
+432
+52% +$25K ﹤0.01% 1494
2024
Q2
$38K Buy
831
+65
+8% +$2.97K ﹤0.01% 1745
2024
Q1
$51K Buy
+766
New +$51K ﹤0.01% 1547